Novartis Pharmaceuticals Corporation - The Lash Group
ent_e53e64648a5edcbdf4f16eb4
Disclosures
2
State AG · 2 jurisdictions
Multi-filing incidents
1
incidents joining 2+ filings here
Max affected reported
2,520
as filed · State AG WA
Leak-site claims
0
none in sample
Identity resolution
- Canonical name
- Novartis Pharmaceuticals Corporation - The Lash Group
- Normalized
- novartis pharmaceuticals corporation the lash— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- No match
- SEC EDGAR CIK
- None — not an SEC registrant
- Domain
- None on record
Disclosure history (2)newest first
- Montana State AGas victim2024-05-22
Cencora, Inc. notified Montana residents that personal and health information for patients of Novartis Pharmaceuticals Corporation was exfiltrated from Cencora's systems. Cencora discovered the unauthorized access on February 21, 2024, and confirmed the impact on April 10, 2024. Affected data included names, addresses, DOBs, diagnoses, and medications. Cencora engaged law enforcement and cybersecurity experts, and is offering two years of credit monitoring via Experian.
- Washington State AGas victim2024-05-22
Cencora, Inc. reported a cybersecurity incident affecting Novartis Pharmaceuticals Corporation patient support data. On Feb 21, 2024, Cencora detected unauthorized exfiltration of PHI and PII (names, DOB, diagnoses, prescriptions). 2,520 Washington residents affected. Cencora engaged law enforcement and forensic experts, provided 2 years of credit monitoring via Experian.